Company intelligence / Profile preview

Anivive Lifesciences

Long Beach, California, United Statesanivive.com ↗
Ownership
Private
Development stage
Other
01

Overview

Anivive has developed the first oral pill approved to treat canine lymphoma and is advancing a first-in-class antifungal vaccine for Valley Fever in dogs—currently under USDA review—with plans to adapt this technology for human use. The company’s pipeline includes eight+ innovative programs targeting cancer, viral infections like FIP/COVID‑19, fungal diseases such as blastomycosis/Valley Fever, with multiple products approaching commercialization

Therapeutic areas
OncologyInfectious Diseases
Modalities
VaccinesSmall moleculesAntiviralsBiologics (implied by vaccine and infectious disease focus)
Industry
Veterinary
02

Drug pipeline

3 assets

GC-376

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

National Institute of Allergy and Infectious Diseases/National Institutes of Health ($33M contract for human valley fever vaccine development)Petco Love Foundation (“Petco Love Joins Forces With Anivive” campaign against valley fever)Recipharm CDMO (contract manufacturing support)Quigley BioPharma LLC & Latham BioPharm Group/Sia Partners [program management/support services]University of Arizona College of Medicine – Valley Fever Center for Excellence [academic collaboration]

Beyond the preview

Go deeper on Anivive Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anivive Lifesciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call